latest news releases from the newsroom
Franklin Electric Co., Inc.
Franklin Electric Reports Record Second Quarter 2014 Sales
FORT WAYNE, Ind., July 28, 2014 (GLOBE NEWSWIRE) -- Franklin Electric Co., Inc. (Nasdaq:FELE) reported second quarter 2014 adjusted earnings per share (EPS) of $0.60 compared to 2013 second quarter adjusted EPS of $0.59, a 2 percent increase (see table below for a reconciliation of GAAP EPS to the adjusted EPS). In the second quarter of 2014, the Company's GAAP fully diluted EPS was $0.55 which was down 5 percent to the GAAP fully diluted EPS from the second quarter of 2013.
Flexion Therapeutics, Inc.
Flexion Therapeutics and Southwest Research Institute(R) (SwRI(R)) Sign Worldwide Exclusive License for Proprietary Microsphere Manufacturing Technologies
BURLINGTON, Mass., July 28, 2014 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it has executed an exclusive worldwide licensing agreement with SwRI to utilize proprietary microsphere manufacturing technologies for production of Flexion's sustained-release drug candidates, including leading candidate FX006. The SwRI technologies employ a uniquely controlled and continuous atomizing technology that Flexion believes may facilitate efficient scale-up of Phase 3 clinical trial material and commercial supply. Flexion has successfully used this technology to produce clinical trial microsphere product for its lead drug candidate FX006, which has been tested in more than 200 patients.
CareDx Presents Cell-Free DNA Biomarker Results in Heart and Kidney Transplant Recipients at the World Transplant Congress
BRISBANE, Calif., July 28, 2014 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value, non-invasive surveillance solutions for transplant recipients today announced the results of its cohort studies of blood samples from the multicenter CARGO and CARGO II heart transplant observational studies, and from the KARGO kidney transplant study during a presentation today at The World Transplant Congress in San Francisco, CA.
Side-by-Side Operation of Luverne Plant on Track
ENGLEWOOD, Colo., July 28, 2014 (GLOBE NEWSWIRE) -- Gevo, Inc. (Nasdaq:GEVO) today reported an update on the progress of the implementation of the Side-by-Side operational mode (SBS) of its plant in Luverne, MN. In the beginning of June, Gevo commenced the co-production of isobutanol and ethanol, with one fermenter dedicated to isobutanol production and three fermenters dedicated to ethanol production. This follows the company's announcement in May that it had begun production of ethanol. The benefits of simultaneously producing isobutanol and ethanol using the SBS are:
EZCORP Adds Four New Directors
AUSTIN, Texas, July 28, 2014 (GLOBE NEWSWIRE) -- EZCORP, Inc. (Nasdaq:EZPW), a leading provider of instant cash solutions for consumers, today announced that its Board of Directors has expanded its size to seven and has elected Mark E. Kuchenrither, Joseph L. Rotunda, Thomas C. Roberts, and Peter Cumins to serve as directors.
Gordon Sangster to Join Codexis as Senior Vice President & Chief Financial Officer
REDWOOD CITY, Calif., July 28, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that Gordon Sangster has agreed to join Codexis as Senior Vice President & Chief Financial Officer. Gordon, who will start on August 18, 2014, will manage all aspects of Codexis' financial and accounting functions and will report to John Nicols, President & Chief Executive Officer.